"Vliv z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F" . "Barto\u0161ov\u00E1, Kate\u0159ina" . "2011-09-14+02:00"^^ . . . "239295" . "Kep\u00E1k, T." . . . . . . . . "Slez\u00E1\u010Dkov\u00E1, Alena" . . . "[06DBDAE56FC0]" . "Vliv z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F"@cs . . . "Psychosoci\u00E1ln\u00ED probl\u00E9my po prod\u011Blan\u00E9 l\u00E9\u010Db\u011B d\u011Btsk\u00E9 malignity jsou vedle zdravotn\u00EDch probl\u00E9m\u016F nejz\u00E1va\u017En\u011Bj\u0161\u00EDmi n\u00E1sledky protin\u00E1dorov\u00E9 terapie. V p\u0159edkl\u00E1dan\u00E9 studii se zab\u00FDv\u00E1me vlivem z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F. Soubor tvo\u0159ilo 95 b\u00FDval\u00FDch onkologick\u00FDch pacient\u016F (47 chlapc\u016F a 48 d\u00EDvek) ve v\u011Bku 13 \u2013 19 let, kte\u0159\u00ED byli 2 \u2013 5 let v remisi. Pro zji\u0161\u0165ov\u00E1n\u00ED kvality \u017Eivota jsme pou\u017Eili dotazn\u00EDk MMQL (Minnesota-Minneapolis Quality of Life Instrument), z\u00E1va\u017Enost n\u00E1sledk\u016F l\u00E9\u010Dby byla hodnocena na \u010Dty\u0159bodov\u00E9 \u0161k\u00E1le dle CTCAE (Common Terminology Criteria for Adverse Events v3.0). Z\u00E1va\u017Enost pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby ovliv\u0148uje negativn\u011B u dosp\u00EDvaj\u00EDc\u00EDch fyzick\u00FD v\u00FDkon, kognitivn\u00ED fungov\u00E1n\u00ED, spokojenost s vlastn\u00EDm t\u011Blem a zapojen\u00ED do soci\u00E1ln\u00EDch vztah\u016F. Psychologick\u00E9 (emo\u010Dn\u00ED) fungov\u00E1n\u00ED a \u017Eivotn\u00ED spokojenost nejsou pozdn\u00EDmi n\u00E1sledky l\u00E9\u010Dby v\u00FDrazn\u011Bji zasa\u017Eeny."@cs . "Brno" . "Soci\u00E1ln\u00ED procesy a osobnost. \u010Clov\u011Bk na cest\u011B \u017Eivotem: k\u0159i\u017Eovatky a mosty" . "Vliv z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F" . "Psychosoci\u00E1ln\u00ED probl\u00E9my po prod\u011Blan\u00E9 l\u00E9\u010Db\u011B d\u011Btsk\u00E9 malignity jsou vedle zdravotn\u00EDch probl\u00E9m\u016F nejz\u00E1va\u017En\u011Bj\u0161\u00EDmi n\u00E1sledky protin\u00E1dorov\u00E9 terapie. V p\u0159edkl\u00E1dan\u00E9 studii se zab\u00FDv\u00E1me vlivem z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F. Soubor tvo\u0159ilo 95 b\u00FDval\u00FDch onkologick\u00FDch pacient\u016F (47 chlapc\u016F a 48 d\u00EDvek) ve v\u011Bku 13 \u2013 19 let, kte\u0159\u00ED byli 2 \u2013 5 let v remisi. Pro zji\u0161\u0165ov\u00E1n\u00ED kvality \u017Eivota jsme pou\u017Eili dotazn\u00EDk MMQL (Minnesota-Minneapolis Quality of Life Instrument), z\u00E1va\u017Enost n\u00E1sledk\u016F l\u00E9\u010Dby byla hodnocena na \u010Dty\u0159bodov\u00E9 \u0161k\u00E1le dle CTCAE (Common Terminology Criteria for Adverse Events v3.0). Z\u00E1va\u017Enost pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby ovliv\u0148uje negativn\u011B u dosp\u00EDvaj\u00EDc\u00EDch fyzick\u00FD v\u00FDkon, kognitivn\u00ED fungov\u00E1n\u00ED, spokojenost s vlastn\u00EDm t\u011Blem a zapojen\u00ED do soci\u00E1ln\u00EDch vztah\u016F. Psychologick\u00E9 (emo\u010Dn\u00ED) fungov\u00E1n\u00ED a \u017Eivotn\u00ED spokojenost nejsou pozdn\u00EDmi n\u00E1sledky l\u00E9\u010Dby v\u00FDrazn\u011Bji zasa\u017Eeny." . . . "5"^^ . "Sobotkov\u00E1, Veronika" . . "T\u00F3thov\u00E1, K." . "Krom\u011B\u0159\u00ED\u017E" . "RIV/68081740:_____/11:00367013" . "4"^^ . "Impact of late effects severity of anticancer therapy on subjective quality of life of childhood cancer survivors"@en . . "7"^^ . "P(GAP407/11/2421), Z(AV0Z70250504)" . . . . . "Impact of late effects severity of anticancer therapy on subjective quality of life of childhood cancer survivors"@en . . . "RIV/68081740:_____/11:00367013!RIV12-AV0-68081740" . "Vliv z\u00E1va\u017Enosti pozdn\u00EDch n\u00E1sledk\u016F l\u00E9\u010Dby na subjektivn\u00ED kvalitu \u017Eivota d\u011Btsk\u00FDch onkologick\u00FDch pacient\u016F"@cs . "Psychosocial problems of patients who underwent childhood malignancy treatment are together with health problems the most severe consequences of anticancer therapy. In this study, we deal with relationship between severity of late effects and subjective quality of life of childhood cancer survivors. The sample consisted of 95 cancer survivors (47 boys and 48 girls) aged 13 to 19 who were in remission for 2 to 5 years at the time of examination. To measure quality of life we used the Minnesota-Minneapolis Quality of Life Instrument (MMQL), severity of late effects we assessed on 4-point scale in accordance with CTCAE (Common Terminology Criteria for Adverse Events v3.0). Severity of late effects of anticancer therapy influences negatively physical functioning, cognitive functioning, body image and social functioning. Psychological (emotional) functioning and outlook of life are not significantly impacted by severity of late effects."@en . "Jel\u00EDnek, Martin" . "978-80-263-0029-8" . "childhood cancer survivors; quality of life; late effects"@en . "Psychologick\u00FD \u00FAstav Filozofick\u00E9 fakulty Masarykovy univerzity a Tribun EU" . "Blatn\u00FD, Marek" .